OBJECTIVE
To investigate short-term response rate, quality of life and toxicities of mannan peptide combined with TP regimen in treating patients with non-small cell lung cancer (NSCLC).
METHODS
Forty one patients with NSCLC were divided into an experimental group treated with TP regimen combined